These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7967162)

  • 1. An immunohistochemical study on pulmonary surfactant of infants diagnosed as sudden infant death syndrome.
    Funayama M; Kageyama N; Ohtani S; Tokudome S; Tabata N; Morita M
    Nihon Hoigaku Zasshi; 1994 Aug; 48(4):225-30. PubMed ID: 7967162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-neonatal drop in alveolar SP-A expression: biological significance for increased vulnerability to SIDS?
    Stray-Pedersen A; Vege A; Stray-Pedersen A; Holmskov U; Rognum TO
    Pediatr Pulmonol; 2008 Feb; 43(2):160-8. PubMed ID: 18085709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in lung surfactant lipids associated with the sudden infant death syndrome.
    Gibson RA; McMurchie EJ
    Aust Paediatr J; 1986; 22 Suppl 1():77-80. PubMed ID: 3790008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of human pulmonary surfactant apoproteins with monoclonal antibodies. Pathologic application for hyaline membrane disease.
    Kuroki Y; Dempo K; Akino T
    Am J Pathol; 1986 Jul; 124(1):25-33. PubMed ID: 3524252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical localization of surfactant apoproteins in usual interstitial pneumonia associated with pulmonary carcinoma.
    Chung JH; Kitaichi M; Ham EK; Seo JW
    Microsc Res Tech; 1998 Aug; 42(3):234-8. PubMed ID: 9764924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical studies on the expression of pulmonary surfactant apoproteins in human lung carcinomas using monoclonal antibodies.
    Dempo K; Satoh M; Tsuji S; Mori M; Kuroki Y; Akino T
    Pathol Res Pract; 1987 Oct; 182(5):669-75. PubMed ID: 2825147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse alveolar damage and acute interstitial pneumonitis: histochemical evaluation with lectins and monoclonal antibodies against surfactant apoprotein and collagen type IV.
    Sugiyama K; Kawai T
    Mod Pathol; 1993 May; 6(3):242-8. PubMed ID: 8346171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of pulmonary intra-alveolar hemorrhage in cases of sudden infant death due to SIDS in a safe sleep environment or to suffocation.
    Krous HF; Haas EA; Masoumi H; Chadwick AE; Stanley C
    Forensic Sci Int; 2007 Oct; 172(1):56-62. PubMed ID: 17222997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unclassified sudden infant death associated with pulmonary intra-alveolar hemosiderosis and hemorrhage.
    Masoumi H; Chadwick AE; Haas EA; Stanley C; Krous HF
    J Forensic Leg Med; 2007 Nov; 14(8):471-4. PubMed ID: 17961871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of pulmonary and intrathymic hemosiderin deposition in sudden infant death syndrome.
    Byard RW; Stewart WA; Telfer S; Beal SM
    Pediatr Pathol Lab Med; 1997; 17(2):275-82. PubMed ID: 9086534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary intra-alveolar hemorrhage in SIDS and suffocation.
    Krous HF; Chadwick AE; Haas EA; Stanley C
    J Forensic Leg Med; 2007 Nov; 14(8):461-70. PubMed ID: 17254829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medial smooth muscle thickness in small pulmonary arteries in sudden infant death syndrome revisited.
    Krous HF; Floyd CW; Nadeau JM; Silva PD; Blackbourne BD; Langston C
    Pediatr Dev Pathol; 2002; 5(4):375-85. PubMed ID: 12016526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden infant death syndrome risk factors with regards to sleep position, sleep surface, and co-sleeping.
    Alexander RT; Radisch D
    J Forensic Sci; 2005 Jan; 50(1):147-51. PubMed ID: 15831009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant protein A and D gene polymorphisms and protein expression in victims of sudden infant death.
    Stray-Pedersen A; Vege A; Opdal SH; Moberg S; Rognum TO
    Acta Paediatr; 2009 Jan; 98(1):62-8. PubMed ID: 18983439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased lung surfactant disaturated phosphatidylcholine in sudden infant death syndrome.
    Gibson RA; McMurchie EJ
    Early Hum Dev; 1988; 17(2-3):145-55. PubMed ID: 3208671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modifiable risk factors of sudden infant death syndrome (SIDS). The current guidelines for reducing the risk of SIDS].
    Wasilewska J; Kaczmarski M
    Wiad Lek; 2009; 62(1):30-6. PubMed ID: 19817255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxic-ischemic changes in SIDS brains as demonstrated by a reduction in MAP2-reactive neurons.
    Oehmichen M; Woetzel F; Meissner C
    Acta Neuropathol; 2009 Mar; 117(3):267-74. PubMed ID: 19009302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sleeping position for preterm infants].
    Poets CF; Bodman Av
    Z Geburtshilfe Neonatol; 2008 Feb; 212(1):27-9. PubMed ID: 18293260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary surfactant. II. In sudden infant death syndrome.
    Hill CM; Brown BD; Morley CJ; Davis JA; Barson AJ
    Early Hum Dev; 1988 Mar; 16(2-3):153-62. PubMed ID: 3378521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibromuscular hyperplasia of the pulmonary artery in sudden infant and perinatal unexpected death.
    Ottaviani G; Lavezzi AM; Matturri L
    Cardiovasc Pathol; 2009; 18(4):223-30. PubMed ID: 18703356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.